Hi again,
to correct what had posted - yes ResApp is aiming to be accepted as a valid screening test - not diagnostic test.
following on from my post I don't realistically see how ResApp Dx will be able to screen for asymptomatic patients - ( no symptoms, no cough , no shortness of breath - my guess accuracy well below 50%. In symptomatic patients with a cough - accuracy maybe 70-80%. In patients with Covid pneumonia - I'd be hoping for 80-90%+. no word from management how much longer we will have to wait for results.
I did hear that the sleepcheck meeting with FDA went very well and that they are confident of approval in coming months.
In the meantime I see revenues building and giving confidence to shareholders ...
- Forums
- ASX - By Stock
- RAP
- COVID-19 Instant Screening test
COVID-19 Instant Screening test, page-550
-
- There are more pages in this discussion • 472 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online